Use of varenicline or a salt thereof in the preparation of a pesticide for pest control

By using vareniclan or its salts as nAChR agonists, the problem of resistance of whiteflies to neonicotinoid insecticides has been solved, achieving highly efficient control of whiteflies and other pests, especially whiteflies carrying nAChR β1 subunit mutations. It also has high safety and is suitable for the control of a variety of pests.

CN123100648APending Publication Date: 2026-11-17INSTITUTE OF VEGETABLES & FLOWERS CHINESE ACADEMY OF AGRICULTURAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611606142.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-16
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Whiteflies have developed strong resistance to neonicotinoid insecticides, and current technologies are insufficient to effectively control whiteflies and other agricultural pests carrying the nAChR β1 subunit mutation.

Method used

Vareniclan or its salts are used as nAChR agonists to prepare pesticides for pest control. They exhibit high insecticidal activity against whiteflies and other agricultural pests, especially against whiteflies carrying the nAChR β1 subunit mutation.

Benefits of technology

Vareniclan exhibits highly effective insecticidal activity against whiteflies, whiteflies carrying the nAChR β1 subunit mutation, and other pests such as peach aphids and thrips. It also has low toxicity to mammals, and its preparation process is simple and easy to promote.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100648A_ABST
    Figure CN123100648A_ABST
Patent Text Reader

Abstract

The application discloses application of varenicline or a salt thereof in preparation of a pesticide for pest control. Experiments prove that varenicline has high insecticidal activity on Bemisia tabaci, can also kill Bemisia tabaci with high efficiency and neonicotinoid insecticide target resistance, has insecticidal activity on Myzus persicae and thrips, has small mammal toxicity, is a kind of efficient, safe, simple-preparation-process pest control drug, and is easy to popularize and produce. The application provides a selectable drug source for Bemisia tabaci control, Bemisia tabaci neonicotinoid insecticide target resistance treatment and other agricultural pest control.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the fields of biotechnology and plant protection, specifically relating to the application of vareniclan or its salts in the preparation of pesticides for pest control. Background Technology

[0002] The whitefly (Bemisia tabaci) is a global agricultural pest, widely distributed in over 90 countries and regions worldwide, damaging more than 500 host plants belonging to 74 families. It is also a vector for many plant viruses, often causing significant economic losses to agricultural production. Therefore, the control of whiteflies is of great importance for protecting agricultural production.

[0003] Chemical control is one of the most effective methods for controlling whiteflies, with neonicotinoid insecticides being particularly effective. These insecticides act on insect nicotinic acetylcholine receptors (nAChRs), mediating highly efficient insecticidal activity by specifically disrupting the insect's neural signal transmission. However, with the long-term use of neonicotinoid insecticides, whiteflies have developed strong resistance. In recent years, cases of whiteflies developing resistance to neonicotinoid insecticides have been reported both domestically and internationally, and the resistance is generally very high. Therefore, insecticide resistance is one of the main reasons why whiteflies are currently difficult to control.

[0004] Research on the resistance mechanisms of whiteflies to neonicotinoid insecticides reveals two main mechanisms: detoxification metabolic resistance and target resistance caused by target mutations. Regarding detoxification resistance, insects exhibiting this resistance typically overexpress genes involved in detoxification metabolism, such as cytochrome P450, carboxylesterase, and glutathione transferase. This results in a stronger metabolic capacity for the pesticide, leading to resistance. For this type of resistance, control strategies generally employ double-stranded RNA (dsRNA) pesticides or inhibitor-type drugs to suppress the main detoxification genes or their upstream regulatory genes, thereby enhancing the effectiveness of neonicotinoid insecticides.

[0005] On the other hand, it has been reported that whiteflies have evolved target resistance to neonicotinoid insecticides due to mutations in their nicotinic acetylcholine receptor (nAChR) gene. A 2024 report on whitefly nAChR revealed a combined A58T and R79E mutation (A58T&R79E) at the 58A and 79R sites of the nAChR β1 subunit. This mutant genotype was confirmed to mediate resistance in whiteflies to seven neonicotinoid insecticides by hundreds of times. Furthermore, a 2026 study detected whiteflies with 79E or A58T&R79E mutations in the nAChR β1 gene on a large scale in domestic fields, and the mutation rate was positively correlated with resistance levels. High mutation rate whitefly populations in several regions exhibited extremely high resistance to neonicotinoid insecticides. This indicates that the two mutant genotypes of the nAChR β1 gene, 79E and A58T&R79E, have spread and become prevalent in China, posing another significant threat to the field control efficacy of whiteflies. Due to the mutation of their drug target, it is currently impossible to use synergists to assist neonicotinoid insecticides in control. There is a need to find a new small molecule structure that can effectively control both the existing nAChR mutant whiteflies and those without mutations.

[0006] Therefore, drug development targeting the β1 subunit mutation of nAChR in whiteflies is one of the major problems that urgently need to be solved in both theoretical research and field control of whiteflies. Small molecule drugs have advantages such as high efficiency, low cost, and flexible and convenient application, making the search for novel small molecule drugs one of the effective methods to solve this problem.

[0007] varenicline, with the molecular formula C 13 H 13 N3, the structural formula is as follows:

[0008]

[0009] It is a partial agonist of mammalian α4β2 nAChR, frequently used for nicotine withdrawal to help smokers quit. No research has been reported to date on its use in agricultural pest control. Summary of the Invention

[0010] The technical problem to be solved by this invention is to provide a compound for the control of whiteflies and nAChR-targeted mutant whiteflies, as well as for the control of other agricultural pests. This compound is varenicline, belonging to the nAChR agonist class of compounds. It exhibits high insecticidal activity against whiteflies and is also highly effective in killing neonicotinoid insecticide-resistant whiteflies. Furthermore, it has insecticidal activity against peach aphids and thrips, and exhibits low toxicity to mammals. It is a highly effective, safe, and simple-to-prepare pest control agent, easy to promote and produce, and can be used to control whiteflies and other agricultural pests.

[0011] This invention mainly discovers that varenicline has high insecticidal activity against whiteflies and nAChR-targeted mutant whiteflies, as well as peach aphids and thrips. Electrophysiological experiments reveal that varenicline has an agonist effect on whitefly nAChR, and that the 79E and 58T&79E nAChR mutants are equally sensitive to varenicline than the wild-type nAChR. Therefore, it can be used for the control of whiteflies and other agricultural pests, as well as for the management of neonicotinoid insecticide target resistance in whiteflies.

[0012] This invention employs a feeding pouch method to conduct bioassays on whiteflies and β1 subunit mutant whiteflies, revealing that varenicline's median lethal concentration (LD50) for both wild-type and mutant-resistant whiteflies is approximately 1 mg / L. Electrophysiological experiments were conducted after expressing whitefly α3β1 nAChR in Xenopus oocytes and administering varenicline to the oocytes. The results showed that varenicline, at low concentrations, elicited an agonist effect on wild-type and β1-79E and β1-58T&79E mutant whiteflies (nAChR), indicating that whitefly nAChR is a target of varenicline. Furthermore, the 58T and 79E mutations on the β1 subunit did not reduce the sensitivity of whiteflies to varenicline nAChR. In addition, this invention used a leaf-dip method to determine the sensitivity of peach aphids and thrips to varenicline, finding that varenicline is also effective in controlling peach aphids and thrips, further validating its potential for controlling other agricultural pests and its broad-spectrum insecticidal activity. In summary, vareniclan can be used as a small molecule compound targeting insect nAChR in agricultural pest control.

[0013] Therefore, the present invention provides the following technical solution:

[0014] Application of varenicline or its salts in the preparation of pesticides for pest control. Varenicline (CAS No.: 249296-44-4), molecular formula: C 13 H 13 N3, structural formula: .

[0015] The salt is in the form of varenicline tartrate or varenicline hydrochloride salt, with varenicline as the active ingredient.

[0016] Specifically, the whitefly is a B / Q biotype whitefly, or the whitefly is a neonicotinoid insecticide target-resistant whitefly.

[0017] More specifically, the nicotinic acetylcholine receptor β1 subunit of the whitefly carries the R79E or A58T&R79E mutation.

[0018] Specifically, the aphid is the peach aphid; the thrips is the bean thrips, the western flower thrips, or / and the melon thrips.

[0019] In a specific embodiment, the pesticide contains vareniclan or its salt at an insecticidal effective amount greater than 0.01 mg / L.

[0020] In practical applications, the pesticide formulations are powders, wettable powders, granules, soluble powders, water-dispersible granules, fumigants, emulsifiable concentrates, suspension concentrates, soluble concentrates, oils, fumigants, poison baits, or microcapsule suspensions.

[0021] This invention also provides a method for controlling pests, which involves applying an effective amount of vareniclan or its salt or structural analogue to the site where pest control is required. The chemical structural formula of vareniclan is as follows:

[0022] ;

[0023] The pests mentioned are whiteflies, aphids, or thrips.

[0024] Specifically, the salt is in the form of vareniclan tartrate or vareniclan hydrochloride salt containing vareniclan as the active ingredient; the whitefly is a B / Q biotype whitefly or a neonicotinoid insecticide target-resistant whitefly; the aphid is a peach aphid; and the thrips is a bean thrips, a western flower thrips, or / and a melon thrips.

[0025] The structural analogues are the quinoxaline of the paravarenicline (7,8,9,10-tetrahydro-6H-6,10-methylbridged azetol[4,5-g]quinoxaline) chemical molecule, and the C or N atom of the azetol group can be substituted with hydrogen, halogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C8 cycloalkyl, C6-C 10 Aryl, C5-C 10Compounds produced by substitution with heteroaryl, hydroxyl, C1-C6 alkoxy, amino, C1-C6 alkylamino, di(C1-C6 alkyl)amino, cyano, nitro, carboxyl, C1-C6 ester, C1-C6 amide, sulfonyl, sulfinyl, etc.; compounds produced by replacing part of varenicline quinoxaline with a bicyclic heterocyclic structure of fused bicyclic, bridged, or spirocyclic; compounds produced by adding or removing N atoms, changing the position of N atoms, or replacing them with O or S atoms in p-varenicline methylbridged azeotropes; compounds produced by shortening or lengthening the methylbridge portion of p-varenicline methylbridged azeotropes, changing the composition of the bridge elements, or changing the connection position of the bridge; compounds produced by changing the ring size and atom type of p-varenicline methylbridged azeotropes; and compounds produced by changing the fusion mode of the ring and quinoxaline in p-varenicline methylbridged azeotropes.

[0026] This invention demonstrates through experiments that varenicline has high insecticidal activity against whiteflies, and can also effectively kill neonicotinoid insecticide-resistant whiteflies. It also exhibits insecticidal activity against peach aphids and thrips, and has low toxicity to mammals. It is a highly efficient, safe, and simple-to-prepare insecticide, making it easy to promote and produce. This invention has the following beneficial effects: (1) Varenicline has high insecticidal activity against whiteflies and can be effectively used in whitefly control. (2) Varenicline has high insecticidal activity against nAChR β1 subunit 58T&79E and 79E mutant whiteflies and can be effectively used in the control of whitefly resistance. (3) Varenicline has high insecticidal activity against peach aphids and thrips and can be effectively used in the control of other pests such as peach aphids and thrips. (4) Varenicline acts as an agonist targeting the nAChR of whiteflies, and the existing 58T&79E and 79E nAChR mutants of the β1 subunit of whiteflies remain sensitive to varenicline. (5) This invention has discovered new application value for the known small molecule compound varenicline, using it for the control of whiteflies and agricultural pests, as well as for the management of neonicotinoid insecticide target resistance, thus opening up a new application field for varenicline. This invention provides an alternative drug source for the control of whiteflies, the management of whitefly neonicotinoid insecticide target resistance, and the control of other agricultural pests. Attached Figure Description

[0027] Figure 1 Sensitivity determination of whiteflies to varenicline.

[0028] Figure 2 Sensitivity determination of neonicotinoid insecticide target resistant whiteflies to varenicline, where A represents the sensitivity of nAChR β1-79E mutant whiteflies to varenicline, and B represents the sensitivity of nAChR β1-58T&79E mutant whiteflies to varenicline.

[0029] Figure 3Exogenous expression of nAChR in whiteflies.

[0030] Figure 4 The effect of the 58T & 79E mutation in the β1 subunit of the whitefly on the electrophysiological effects of neonicotinoid insecticides.

[0031] Figure 5 Electrophysiological dose-response curves of varenicline in whiteflies nAChR.

[0032] Figure 6 The maximum reactive current of vareniclan in whiteflies nAChR.

[0033] Figure 7 Sensitivity determination of peach aphid to varenicline.

[0034] Figure 8 Sensitivity determination of thrips to varenicline. Detailed Implementation

[0035] The following experimental examples further illustrate the beneficial effects of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0036] Example 1: Insecticidal activity of varenicline against whiteflies

[0037] To determine the insecticidal activity of varenicline against whiteflies, a varenicline efficacy experiment was conducted on whiteflies using the feeding pouch method.

[0038] 1.1 Experimental Materials

[0039] The tested whiteflies were an indoor pesticide-sensitive population, collected in Haidian District, Beijing in 2000, and raised on cotton plants without exposure to any insecticides.

[0040] The test reagent, varenicline (99%), was purchased from Yuanye Shanghai Technology Co., Ltd., and dissolved in dimethyl sulfoxide (DMSO) to prepare a 10 mM stock solution.

[0041] 1.2 Experimental Methods

[0042] The bioassay for whiteflies was performed using the feeding pouch method, with the specific procedure as follows: The whitefly feeding solution was formulated with 5% yeast extract and 30% sucrose, and sterilized using a 0.22μm filter. Vareniclan stock solution was diluted with the feeding solution to prepare five concentrations: 10, 3, 1, 0.3, and 0.1 ppm. A hollow glass tube device (50mm long, 15mm in diameter) with openings at both ends was used. A sealing film was stretched as thinly as possible to cover one end of the glass tube. 70μL of the prepared vareniclan feeding solution was dotted in the center of the sealing film. Then, another layer of sealing film was stretched over the solution, and the second layer was pressed down to evenly distribute the solution between the two layers, forming a whitefly feeding pouch device. Twenty whiteflies were placed into the device, and the other opening of the glass tube was sealed with the sealing film. Several holes were simultaneously pricked at this opening with a needle for ventilation. The feeding device was sealed with a black plastic shell, leaving only the liquid feeding end exposed. The whiteflies were attracted to the liquid by light, causing them to stop and feed. After 48 hours, the mortality rate of the whiteflies was observed. The feeding device was gently tapped; any unresponsive whiteflies were considered dead. The median lethal concentration (LC50) of the pesticide was calculated using POLO Plus 2.0 software. 50 Imidacloprid was used as a control agent to measure efficacy. The feeding liquid volume was also set at 70 μL, and five feeding concentrations were set at 50, 40, 8, 4 and 2 ppm.

[0043] 1.3 Experimental Results

[0044] Experimental results are as follows Figure 1 As shown, vareniclan's LC50 against whiteflies 50 The value was 0.37 mg / L, and the LC50 of imidacloprid against whiteflies in the control group was... 50 The concentration was 5.40 mg / L. To achieve an equivalent insecticidal effect, the dosage of imidacloprid was 14.59 times that of varenicline. This demonstrates that varenicline has superior insecticidal activity against whiteflies compared to imidacloprid, making it a highly effective insecticide that can be readily applied to the control of whiteflies.

[0045] Example 2: Insecticidal activity of varenicline against neonicotinoid insecticide-resistant whiteflies

[0046] To clarify the insecticidal activity of varenicline against neonicotinoid insecticide-resistant whiteflies, a varenicline efficacy experiment was conducted on neonicotinoid insecticide-resistant whiteflies using a feeding pouch method. Specifically, the whitefly population referred to was a field-collected and identified nAChR β1 subunit 79E and 58T&79E mutant resistant population.

[0047] 2.1 Experimental Materials

[0048] The tested whiteflies were two field populations of neonicotinoid insecticide-resistant whiteflies, denoted as populations R#1 and R#2. R#1 was a whitefly with the nAChR β1 subunit A58T & R79E mutant collected in Urumqi, Xinjiang in 2019, with a mutation rate of 100%. R#2 was a whitefly with the β1 subunit R79E mutant collected in Yueyang, Hunan in 2023, with a mutation rate of 85%.

[0049] 2.2 Experimental Methods

[0050] The bioassay for whiteflies was performed using the feeding pouch method. The specific operation method is described in Experiment 1.2 of the Examples. Imidacloprid was used as a control agent to measure the efficacy.

[0051] 2.3 Experimental Results

[0052] Experimental results are as follows Figure 2 As shown in Figures A and B, for the nAChR β1 subunit 79E mutant whitefly population, the LC of the vareniclan plant... 50 The value was 1.31 mg / L, while the LC50 of the control group imidacloprid was... 50 The value was 39.53 mg / L, achieving an equivalent insecticidal effect; the dosage of imidacloprid was 30.18 times that of varenicline. For the nAChR β1 subunit 58T&79E mutant whitefly population, the LC50 of varenicline was... 50 The value was 0.76 mg / L, while the LC50 of the control group imidacloprid was... 50 The concentration was 88.39 mg / L, achieving an equivalent insecticidal effect. The dosage of imidacloprid was 116.3 times that of varenicline. This demonstrates that varenicline exhibits superior insecticidal activity against neonicotinoid-resistant whiteflies, demonstrating high insecticidal activity and making it well-suited for the management of neonicotinoid-resistant whiteflies.

[0053] Example 3: Electrophysiological activity of varenicline against nAChR in whiteflies

[0054] I. Exogenous expression of nAChR in whiteflies and verification of drug resistance function at the nAChRβ1-58T & 79E sites

[0055] Since nAChR is a pentameric protein composed of five subunits, its β1 subunit typically needs to assemble with the α subunit to achieve functional activity. Furthermore, the correct expression of insect nAChR depends on three cofactors: unc50, unc74, and Ric3 genes. Therefore, to exogenously express active whitefly nAChR for subsequent drug target effect detection and functional verification of the 58T&79E mutation on the β1 subunit, the inventors combined eight α subunit genes of the whitefly with the β1 subunit gene, and co-expressed these combinations with the aforementioned three whitefly nAChR cofactors in Xenopus oocytes. Electrophysiological detection of the expressed nAChR's response to acetylcholine confirmed its expression activity.

[0056] 3.1 Experimental Materials

[0057] The African clawed frogs used in the experiment were purchased from the Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences.

[0058] 3.2 Experimental Methods

[0059] The electrophysiological expression system employed a combination expression of the eight α subunits of the whitefly with the β1 subunit to detect potentially active combinations. The system also included three nAChR cofactors: unc50, unc74, and Ric3, with a 1:1 ratio of cRNA to each gene. Selected genes were constructed into the pGH19 vector, linearized using NotI high-fidelity enzyme, and then cRNA was synthesized using the mMESSAGE mMACHINE® Kit (Thermofisher, AM1344). Each oocyte was injected with a 36 nL volume and a concentration of 500 ng / μL using a NanoInject III microinjector. After 3 days of oocyte culture, electrophysiological recordings were performed using an Axoclamp 900A oocyte amplifier and Clampex software. The cell clamping potential was -70 mV, and the perfusion rate was 8-10 mL / min. The recorded data were analyzed using Clampfit software.

[0060] 3.3 Experimental Results

[0061] The results of exogenous nAChR expression in whiteflies are as follows: Figure 3 As shown, in the combined expression systems of various nAChR α and β1 subunits in whiteflies, two active whitefly nAChR combinations, namely α3β1 and α4β1, were screened at a drug concentration of 100 μM acetylcholine. Since the expression current of the α4β1 combination was relatively weak, subsequent drug analysis examples mainly demonstrate the results of α3β1 nAChR.

[0062] The electrophysiological responses of whitefly α3β1 nAChR and β1-58T&79E mutant nAChR to neonicotinoid insecticides are as follows: Figure 4 As shown, after administering 10 μM imidacloprid and dinotefuran to wild-type α3β1 nAChR, currents of 170.4 nA and 900.6 nA were detected, respectively. After administering 1 mM imidacloprid and dinotefuran to the β1 subunit 58T&79E mutant α3β1 nAChR, no current induced by imidacloprid was detected; the current induced by dinotefuran was only 99.3 nA, a decrease of approximately 89% compared to the wild type.

[0063] The above results indicate that the α3β1 nAChR of the whitefly exhibits good exogenous expression activity and can be used for subsequent target effect detection of varenicline. Meanwhile, the 58T&79E mutation site in the β1 subunit significantly reduced the sensitivity of the whitefly nAChR to neonicotinoid insecticides, demonstrating that this site is a key reason for the insensitivity of mutant whiteflies to neonicotinoid insecticides.

[0064] II. Electrophysiological activity of varenicline against nAChR in whiteflies

[0065] To clarify the target of varenicline in whiteflies, electrophysiological methods were used to analyze the toxicological characteristics of varenicline on whitefly nAChR. Specifically, the whitefly α3β1 nAChR prepared above was used.

[0066] Referring to the aforementioned electrophysiological methods, by setting concentration gradients, the magnitudes of the response currents of nAChR at different drug concentrations were recorded, and dose-response curves were plotted. The half-efficacy concentration (EC50) of the ligand was calculated using nonlinear regression fitting with Graphpad software. 50 )value.

[0067] Experimental results are as follows Figure 5 As shown, varenicline has an agonist effect on the α3β1, β1-79E mutant, and β1-58T&79E mutant nAChR of the whitefly, EC 100%. 50 The values ​​were 0.57, 0.25, and 0.19 μM, respectively, while the EC50 of acetylcholine was... 50 The concentration was 4.34 μM. The sensitivity folds of varenicline to nAChR in whiteflies compared to acetylcholine were 7.61, 17.36, and 22.84, respectively. This indicates that varenicline is a ligand with higher affinity for both wild-type and mutant nAChR in whiteflies than the endogenous neurotransmitter acetylcholine.

[0068] like Figure 6As shown, at the concentration where varenicline achieves its maximum effect on whitefly nAChR (i.e., 10 μM), the maximum currents induced by varenicline on whitefly α3β1, β1-79E mutant, and β1-58T&79E mutant nAChRs were 22.60%, 14.99%, and 22.49% of the currents triggered by acetylcholine at a concentration of 100 μM (the concentration at which acetylcholine triggers the maximum effect current), respectively. This indicates that varenicline is a partial agonist of whitefly nAChR, and there is no significant difference in the maximum effect between wild-type and mutant nAChRs.

[0069] The results show that varenicline is a partial agonist of whitefly nAChR, and its affinity for whitefly nAChR is higher than that of acetylcholine. This indicates that varenicline can act as a partial agonist ligand with high affinity for whitefly nAChR, abnormally activating the whitefly nAChR to achieve insecticidal effects. Meanwhile, the 79E and 58T79E mutants of the whitefly nAChR β1 subunit are also sensitive to varenicline, indicating that the existing whitefly target resistance sites 79E and 58T&79E do not affect the efficacy of varenicline against whitefly nAChR.

[0070] Example 4: Insecticidal activity of varenicline against peach aphids

[0071] 4.1 Experimental Materials

[0072] The tested peach aphid, Myzus persicae, was collected in Pinggu District, Beijing in 2026 and reared on cabbage plants.

[0073] 4.2 Experimental Methods

[0074] The bioassay for the peach aphid was performed using the leaf-dipping method. The pesticide dilution solution was ultrapure water containing 0.1% (v / v) Triton X-100. Six concentration gradients were prepared: 200, 100, 30, 10, 3, and 1 ppm, with each concentration prepared in 50 mL solutions. Fresh cabbage leaves were punched into 2 cm diameter leaf discs, which were then dipped in the diluted pesticide solution for 30 seconds and removed to air dry in a cool place. 2 mL of 2% agar was placed at the bottom of a 12-well culture plate. After drying, the leaf discs were placed on the agar, and 15 adult aphids were inoculated into each well. The plates were sealed with sealing film, with small holes punched for ventilation. The plates were placed in a rearing room at 25°C and 55% humidity. After 48 hours, the mortality rate of peach aphids was recorded; those that did not react when lightly touched with a brush were considered dead. The median lethal concentration (LD50) of the pesticide was calculated using POLO Plus 2.0 software. Imidacloprid was used as a control pesticide to measure efficacy. Six concentration gradients were set: 500, 300, 100, 30, 10, and 3 ppm. The volume of the pesticide solution prepared for each concentration was 50 mL.

[0075] 4.3 Experimental Results

[0076] Experimental results are as follows Figure 7 The LC50 of varenicola against peach aphids was shown. 50 The value was 55.88 mg / L, and the LC50 of imidacloprid against peach aphids in the control group was... 50 The concentration was 193.80 mg / L. To achieve an equivalent insecticidal effect, the dosage of imidacloprid was 3.47 times that of varenicline. This demonstrates that varenicline has superior insecticidal activity against peach aphids compared to imidacloprid and can be effectively applied in the control of peach aphids and other agricultural pests.

[0077] Example 5: Insecticidal activity of varenicline against soybean thrips

[0078] 5.1 Experimental Materials

[0079] The tested thrips, namely Megalurothrips usitatus, Frankliniella occidentalis, and Thrips flevas Schrank, were collected from cowpea plants in Sanya City, Hainan Province in 2026.

[0080] 5.2 Experimental Methods

[0081] The bioassay for thrips was performed using the leaf-dip method. The pesticide dilution solution was ultrapure water containing 0.1% (v / v) Triton X-100, diluted to 12.5 ppm, with a prepared solution volume of 50 mL. 1.5 mL centrifuge tubes were filled with the solution, soaked for 1 hour, then the solution was discarded and the tubes were air-dried in a cool place for subsequent inoculation. Fresh green beans were cut into approximately 1 cm cubes, soaked in the pesticide solution for 30 seconds, and then removed (the blank control group was soaked in an ultrapure water solution with the same solvent content for 30 seconds), and placed in a cool place to air-dry. The green beans were then placed in centrifuge tubes, and approximately 15 thrips were inoculated. The centrifuge tubes were sealed with sealing film, with several small holes for ventilation, and placed in a rearing room at 25°C and 55% humidity. After 48 hours, thrips mortality was recorded; those that did not react when lightly touched with a brush were considered dead.

[0082] 5.3 Experimental Results

[0083] Experimental results are as follows Figure 8 The results showed that at a concentration of 12.5 ppm, vareniclan had average lethalities of 68.61%, 83.05%, and 90.18% against bean thrips, western flower thrips, and melon thrips, respectively, which were significantly different from the corresponding blank control groups (the average mortality rates of bean thrips, western flower thrips, and melon thrips in the blank control group were 3.92%, 1.75%, and 2.85%, respectively). (P<0.001), demonstrating that vareniclan has high insecticidal activity against thrips and can be effectively applied in the control of thrips and other agricultural pests.

Claims

1. The application of vareniclan or its salts in the preparation of pesticides for pest control, characterized in that, The chemical structural formula of the varenicline is as follows: ; The pests mentioned are whiteflies, aphids, or thrips.

2. The application as described in claim 1, characterized in that, The salt is in the form of varenicline tartrate and varenicline hydrochloride salt, with varenicline as the active ingredient.

3. The application as described in claim 1, characterized in that, The whitefly in question is the B / Q biotype whitefly.

4. The application as described in claim 1, characterized in that, The whitefly in question is a neonicotinoid insecticide target-resistant whitefly.

5. The application as described in claim 4, characterized in that, The whitefly's nicotinic acetylcholine receptor β1 subunit carries the R79E or A58T&R79E mutation.

6. The application as described in claim 1, characterized in that, The aphid is the peach aphid; the thrips is the bean thrips, the western flower thrips, or / and the melon thrips.

7. The application as described in claim 1, characterized in that, The pesticide contains vareniclan or its salt at an insecticidal effective amount greater than 0.01 mg / L.

8. The application as described in claim 1, characterized in that, The pesticide formulations are powders, wettable powders, granules, soluble powders, water-dispersible granules, fumigants, emulsifiable concentrates, suspension concentrates, soluble concentrates, oils, fumigants, poison baits, or microcapsule suspensions.

9. A method for controlling pests, characterized in that, Apply an effective amount of vareniclan and its salts or structural analogs to the site where pest control is required. The chemical structural formula of vareniclan is as follows: ; The pests mentioned are whiteflies, aphids, or thrips.

10. The method as described in claim 9, characterized in that, The salt is in the form of vareniclan tartrate salt and vareniclan hydrochloride salt containing vareniclan as the active ingredient. The whiteflies mentioned are either B / Q biotype whiteflies or neonicotinoid insecticide target-resistant whiteflies; The aphid in question is the peach aphid; The thrips mentioned are bean thrips, western flower thrips, or / and melon thrips.